Patients with chronic medically complex disorders like inflammatory bowel diseases (BD) often have mental health and psychosocial comorbid conditions. There is growing recognition that factors other than disease pathophysiology impact patients' health and wellbeing. Provision of care that encompasses medical care plus psychosocial, environmental and behavioral interventions to improve health has been termed "whole person care" and may result in achieving highest health value. There now are multiple methods to survey patients and stratify their psychosocial, mental health and environmental risk. Such survey methods are applicable to all types of IBD programs including those at academic medical centers, independent health systems and those based within independent community practice. Once a practice determines that a patient has psychosocial needs, a variety of resources are available for referral or co-management as outlined in this paper. Included in this white paper are examples of psychosocial care that is integrated into IBD practices plus innovative methods that provide remote patient management. P eople who have an inflammatory bowel disease (IBD) including Crohn's disease and ulcerative colitis suffer from a chronic illness that impacts many aspects of their lives. The burden of IBD is substantial for both individual patients because of their debilitating symptoms and for society because of the cost of longterm treatment. [1] [2] [3] Advances in medical care have been significant during the last decades and have helped patients maintain or regain disease remission while reducing the need for emergency visits and surgery.
However, traditional medical care in the United States tends to focus on biological aspects of disease while often ignoring psychosocial factors. There is a growing recognition that high value care for patients with chronic conditions must include effective management of both biological and psychosocial factors for patients to regain their best health and well-being. 4 The American Gastroenterological Association (AGA) Institute Governing Board recognized a need to provide gastroenterologists with information that would help them incorporate psychosocial aspects of IBD care into their practices. The AGA commissioned a task force to review current literature and identify examples of integrated IBD care within both academic and community settings. The task force performed an extensive literature review, reached out to a sample of practices that have developed such care, and met to identify priorities for this report. This consensus statement summarizes findings and highlights several overarching factors that, if managed well, will enhance IBD care as follows:
Mental health factors with a focus on essential screening and intervention steps Psychosocial factors that warrant identification and intervention. One particularly neglected area in need of better focus is racial/ethnic factors.
Health system factors including barriers to access providers during a disease crisis, financial constraints for both patients and providers, and a lack of readily available resources to deal with positive mental health screens.
Working models of integrated care within academic medical centers and community-based practices are provided as examples of potential solutions and sources of information. We also briefly discuss how the current feefor-service reimbursement model in the United States creates barriers to best practice and how that might be modified. The examples mentioned herein are not exhaustive or endorsed by the AGA, but they are prioritized on the basis of published evidence supporting them.
Statement of the Problem
Patients with medically complex and chronic diseases often have comorbid mental health conditions and psychosocial challenges that, if adequately addressed, are associated with improved health outcomes. [5] [6] [7] [8] [9] [10] Integrating psychosocial care into IBD practices represents an important step toward "whole-person" care. 11 For the purposes of this review, "psychosocial" is defined as psychological symptoms, illness perception, coping, health behaviors, environmental stress, and social/racial/ethnic factors that can impact disease. Psychosocial care refers to management of these domains, provision of emotional support, and practical advocacy for patients. "Mental health" refers to psychiatric diagnoses and their management. "Behavioral" interventions refer to steps that help patients manage psychosocial and mental health challenges.
Traditional medical practices, especially those of specialists, often ignore psychosocial care, despite consensus that health outcomes are affected substantially by such factors. 6, 12 Patients with IBD are known to experience high rates of comorbid anxiety and depression, which via the brain-gut axis can influence mucosal healing and gastrointestinal symptoms. 10, 11, [13] [14] [15] [16] [17] In addition, identification of psychiatric illnesses in IBD patients was predictive of higher annual medical resource utilization and IBD-related costs. 18, 19 Patients with IBD have estimated annual direct health care costs of $1.7 billion, or about $12,000-$20,000 per patient, not including indirect costs such as productivity loss. [20] [21] [22] Eighteen percent of IBD patients account for 80% of total IBD health care burden, with costliest factors being surgery and hospitalization. 21, 22 Although not quantified directly in IBD patients, costs of concurrent depression among patients with chronic disease conditions have been estimated to be $210 billion annually across the 15.5 million adults with major depression in the United States. 23 Psychosocial factors also are linked to disease course, quality of life, and related disability. [24] [25] [26] [27] [28] [29] [30] IBD patients themselves have expressed worries about psychosocial comorbidities, so ignoring such factors adds to patients' burden. 29 Effective psychosocial assessment tools and implementing appropriate interventions for patients with IBD need to be part of a high-quality gastroenterology IBD practice. 30, 31 Although models of integrated IBD care have been described, substantial cultural, practical, and financial barriers remain. Most gastroenterologists are unfamiliar with behavioral health resources. In addition, care management, input from behavioral specialists, nutritional guidance, and after-hour telephone support all lack support within the current health care reimbursement model. Gastroenterologists are not familiar with standard mental health survey tools, and most providers do not know how their patients are faring on a day-to-day basis. The goal of this paper is to provide background knowledge and practical tools for gastroenterology practices to change this paradigm.
Mental Health Factors
Even with the identification of the high burden of psychiatric comorbidities in patients with IBD, 30 integration of behavioral health specialists into IBD practices is relatively new and still rare. Yet, recognition and provision of basic resources for the most common mental health conditions could markedly impact care of IBD patients. [30] [31] [32] The most prevalent mental health conditions in patients with chronic illnesses are depression, anxiety disorders, chronic pain, and fatigue, so these deserve a provider's initial focus. Several ways to build a management program have been identified, with the most effective (albeit the most difficult to build) being a collaborative care model.
Collaborative care, defined as a structured intensive coordination of care between medical and behavioral clinicians, has been part of general primary care since the early 2000s. 25 One landmark randomized controlled trial (Improving Mood-Promoting Access to Collaborative Care Treatment [IMPACT] ) in the United States compared collaborative care with usual care for treatment of late-life depression within primary care practices. 26 One thousand eight hundred one patients were recruited across 18 primary care clinics from 8 health organizations in 5 states. 26 Mental health treatment consisted of 12-month access to a depression care manager within the clinics who offered education, care management, brief psychotherapy, and support for antidepressant management by the primary care physician. Care managers were nurses or psychologists who were supervised by both the medical team and psychiatrists. The IMPACT intervention was associated with reduced depressive symptoms and improved quality of life relative to usual care. 26 In addition, 80 randomized controlled trials have shown collaborative behavioral care is more effective than usual care in reducing the impact of behavioral factors on health. These were summarized in a 2012 Cochrane Summary. 25 Although collaborative care is the gold standard model that integrates psychosocial and other important domains (eg, nutrition) into routine medical care, we recognize that often such an infrastructure is not available to most gastroenterologists. However, there are less resource intense models of integrated care that are effective. For example, simply identifying the existence of mental health problems in a patient (through screening) and providing a list of behavioral resources within a patient's health network are an effective and acceptable first step.
Most patients with IBD consider their gastroenterologist to be their principal provider of medical care, and as such, we should parallel traditional primary care providers with respect to whole-person care. Because depression, anxiety disorders, and chronic pain are the most prevalent comorbid psychiatric disorders in patients with IBD, this paper will examine available tools that can be incorporated into gastroenterology practices.
Available Mental Health Screening and Assessment Tools
A summary of mental health screening and assessment tools for the 3 most common mental health problems (depression, anxiety, and pain) is presented in Table 1 . Included are the names of measures, key references, scoring definitions, and the pros and cons for each from the view of a practicing gastroenterologist.
Depression and anxiety. There are 2 broad ways that depression and anxiety are probed: (1) symptom severity and (2) diagnosis of psychiatric disorders (which consists of symptom count, severity, and associated functional impairment). Some somatic depressive symptoms (fatigue, sleep, appetite) can be attributed to inflammation in IBD, [33] [34] [35] but even these can improve more substantially when psychological interventions are coupled with medical therapies. 33, 34 Available survey instruments for both anxiety and depression include selfreported and clinician-reported measures. Examples of survey tools useful to identify depressive severity and combinations of depression and anxiety are provided in Table 1 and referenced here. [35] [36] [37] [38] [39] [40] [41] [42] Chronic pain. Although pain is an item on many IBD activity indices, chronic pain is such a driver for health utilization and has such a potential for abuse that it is important to have a systematic way to identify it and algorithms to treat it. 43, 44 Chronic pain can lead to longterm opioid use in a subset of patients and can lead further to misuse and addiction. 43, 44 The most common and simplest survey instruments for screening include the Screener and Opioid Assessment for Patients with Pain-revised, a 5-question tool, 45, 46 and the Current Opioid Misuse Measure, a 17-question scale. 47 Both measures can identify at-risk patients quickly, so appropriate referral or development of an opioid contract linked to monitoring and non-opioid treatment strategies can be implemented. 43, 44 Other survey measures to assess pain severity and interference are listed in Table 1 including an example of a visual analogue scale and the Brief Pain Inventory. [48] [49] [50] [51] [52] Management strategies for pain in digestive diseases have been reviewed elsewhere and are beyond the scope of this paper. [53] [54] [55] It is emphasized that gastroenterologists encounter patients with chronic pain frequently and must be prepared at least to identify pain as a significant issue and develop referral resources for its management.
Other Mental Health Symptoms and Concerns
Fatigue and sleep disturbance can be isolated problems or linked to depression, anxiety, and pain. [56] [57] [58] [59] [60] Survey instruments are available to help document objective benchmarks such as hours slept, time to fall asleep (latency), and number of awakenings. [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] Ideal benchmarks are average sleep of 8 hours, latency of less than 30 minutes, and no more than 1 awakening. Sleep outside these parameters could likely benefit from behavioral interventions.
Other areas of patient concern include patients' body image (physical appearance), 66, 67 and an IBD-specific body image scale has been validated. 68 Another focus area is assessing a patient's ability to cope with their disease. [69] [70] [71] [72] [73] There is a promising instrument called Brief COPE, consisting of 14 scales with 28 total items that assess problemfocused, emotional, and maladaptive coping. 71 One newer instrument, mostly used within a research setting, is the National Institutes of Health PatientReported Outcomes Measurement Information System (PROMIS). 74, 75 This is a validated, brief research tool that captures multiple psychosocial domains, although they have not been well-studied in routine clinical care. Studies are beginning to develop clinical thresholds and crossvalidate PROMIS measures with other clinically used instruments. Although PROMIS measures are not IBDspecific, they have been validated in patients with IBD. 75 The survey tools presented above are being adapted into brief patient-reported instruments that take less than a minute for patients to complete. Some can be completed remotely 76 or via tablets or kiosks in offices that directly link the information to the electronic health record. If time or resources are limited, health-related quality of life instruments can serve as brief surveys of sleep, fatigue, pain, tension, depression, and other psychosocial domains. One such instrument, the Short IBD Questionnaire, is validated and available electronically. 77 In summary, it is clear that health-related quality of life assessments should be part of modern IBD care, 78 and most recent guidelines and quality measurement articles emphasize this important aspect of a gastroenterology IBD practice. 79, 80 Behavioral Interventions for Depression, Anxiety, and Chronic Pain
If a practice implements a screening process for mental health disorders, it then becomes imperative that providers respond appropriately to patients who are screen-positive. This raises concerns that practices cannot easily tap behavioral resources in a timely manner, and many providers believe that they lack the time to address psychosocial issues. Providers also fear liability associated with a patient who expresses suicidal thoughts on a depression screen. A recent systematic review for the U.S. Preventive Services Task Force outlines current practice around suicide screening and treatment within a primary care context. 81 Having the names of several local mental health providers and emergency services with availability and a crisis-line phone number is minimally adequate.
Lack of reimbursement for integrated care is also a barrier and will be discussed subsequently. With a national trend toward recommending depressive screening in medical settings, reimbursement models are evolving including billing options for depression screening. Some pharmacologic companies with IBD service lines offer resources to support behavioral staff. Finally, psychiatrists, psychologists, and some social workers can bill under their own licenses and as such can support their salaries.
There is an increasing awareness that even brief behavioral interventions for common psychiatric comorbidities in IBD can be beneficial. [27] [28] [29] [30] Although a comprehensive review of behavioral interventions is outside the scope of this review, several practical points warrant mention. Whenever possible, non-medication options (eg, cognitive behavioral therapy, hypnosis, mindfulness meditation, etc) should be first-line approaches. 34, 82, 83 Because there is still a shortage of behavioral providers trained in these techniques, access to such interventions are becoming increasingly feasible by training medical staff, using health coaches, and the growing availability to these techniques via apps from the Internet. 84, 85 When adjunctive psychotropic medications are necessary (eg, for severe symptoms or inability or resistance to try behavioral therapies), the same guidelines are used as for non-IBD patients. There are several reviews available on specific issues related to the use of psychiatric medications in patients with IBD. 32, 86, 87 Additional Psychosocial Factors Several other psychosocial factors that can affect the quality of life of IBD patients are worth mentioning because they are the focus of increasing research interest. These include race (ethnicity) and sexual identity. 88 Although there has been a white predominance in IBD in the past, recent studies demonstrate an increasing incidence of IBD in minorities. 89 There appears to be differences between whites and non-whites (all minorities) in disease characteristics such as perianal disease, fistulas, and disease location and differences in treatment use such as use of steroids, parenteral nutrition, and biologic drugs. [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] Although genetics may play a role, cultural differences in understanding and accepting treatment approaches may also be important. [97] [98] [99] Providers may have a subtle bias against initiating treatment, medical or surgical, in minority subgroups of patients. 99, 100 Psychosocial factors related to religion and culture may also influence treatment decisions among various demographic groups. One study showed religious connections were stronger for people with IBD versus the general population, providing an important strength area to probe. 99 Once thought to predominantly affect people from Ashkenazi or Eastern European Jewish descent, 100-103 the realization that IBD crosses racial and cultural boundaries means that health care professionals need to educate themselves about how religious and cultural differences affect medical care and patient decisions. [104] [105] [106] Finally, another often neglected area is a focus on gender identity and sexual orientation. Despite growing evidence of psychosocial and medical risks as well as marked disparities associated with lesbian, gay, bisexual, or transgender persons compared with heterosexual individuals, 107, 108 it is a neglected area of research in IBD. A single report from King's College emphasized the need for careful questioning about sexual activity and psychosocial needs of lesbian, gay, bisexual, or transgender IBD patients. 109 
Health System Barriers
There are multiple health system barriers that need to be addressed for a successful integration of behavioral/psychosocial care into IBD clinical settings. These include lack of resources (eg, access to appropriate providers), financial constraints of patients and providers, and lack of appropriate reimbursement models. These issues are especially pertinent as health systems begin to assume financial risk for all aspects of care for groups of patients. 110, 111 Financial, resource, and access to care (especially emergency and urgent care) issues related to mental health screening were addressed above. However, there are broader financial barriers related to IBD care that need to be understood and addressed so that psychosocial domains can be included. One such barrier remains patient-related financial constraints. About 26% of African Americans and 24% of Hispanics in the United States were living in poverty in 2015 compared with 10% of whites. 110 Combining financial insecurity with racial and ethnic disparities was estimated to cost the United States about $60 billion in excess medical costs in 2009, a sum that will increase substantially if not mitigated by effective interventions. 70 After examining multiple psychosocial, racial, ethnic, financial, and gender identity issues affecting the care of IBD patients, the task force searched for ongoing programs from a variety of practice settings that were designed to manage these factors. We identified examples from both community practices and practices (both academic and non-academic) associated with large health systems that have successfully implemented some parts of integrated IBD care.
Examples of Integrated Inflammatory Bowel Disease Care Within Health Systems
Large health systems have capacity that independent practices lack in creating integrated care models, remote monitoring, virtual consultation, and telecommunication. Currently, there are several examples of integrated IBD care within large health systems (this discussion is not all inclusive). 9, 10, 16, 19, 23, 28 There are several structural methods to integrate psychosocial care into a practice. One is coordinated care, which refers to routine screening for comorbid mental health disorders by using basic but evidencebased behavioral health screening tools (Table 1) . Patients who are screen-positive would be referred as needed to pre-identified community resources or mental health professionals. Care coordination would include routine and basic exchanges of information. With this model, a care manager/nurse coordinator could ensure patients' access to mental health providers and follow-up care outside the gastroenterology practice. 9 Integrated care describes a practice where a treatment plan including both physical and behavioral health is an integral part of the initial evaluation and entire care experience. 10 Treatment plans are linked to team-based care, regardless of whether all services are provided in the same location. 10, 16 Financial feasibility remains the greatest issue determining levels of integration in different practice settings. Even in primary care, most integrated care models are grant-funded or developed only when systems change to risk-based or capitated payment models.
An example of an integrated care model is the Wake Forest Baptist Health system that collaborates with CareNet Counseling, the behavioral health subsidiary of Wake Forest Baptist Health.
112 CareNet recruits, hires, and trains mental health professionals, who then are located into various ambulatory care settings and bill under their own professional licenses. Such integration improves referrals to behavioral health services, recognizes diagnosable behavioral issues, and identifies medical non-adherence earlier than traditional services.
The IBD Center at the University of Pittsburgh Medical Center has 2 integrated models of psychosocial care for IBD patients. The first is a model where patients with psychosocial needs identified by the gastroenterologist are referred to a behavioral clinic associated with the Gastroenterology Division, which is called the Visceral Inflammation and Pain Center. 16, 36 The Visceral Inflammation and Pain Center is staffed with psychologists and psychiatrists who bill for services by using medical and mental health billing codes. Initial results evaluating the Visceral Inflammation and Pain model of care have shown positive effects on health outcomes and reduced medical utilization. 16, 36 A second model is a collaborative care model, where behavioral health providers are colocated in the gastroenterology clinic, and structured care plans are co-developed by the medical and behavioral team in an integrated way called Total Care IBD, is a fully integrated subspecialty medical home, and is associated with the University of Pittsburgh Medical Center Health Plan to study volume to value transition in care management with an emerging financial risk sharing reimbursement model. 16 In this model, the gastroenterologist, psychiatrist, social worker, nurse practitioner, nurse, and dietitian form a team to manage high-cost IBD patients. In addition, this program also takes advantage of trained peer specialists to develop an empathic connection with patients, provide education, and serve as a communication liaison to the outpatient Total Care team. 113 The Total Care IBD model was shown to have greater impact on patient adherence to behavioral care than the Visceral Inflammation and Pain Center model when patients screened positive for suicidal thoughts. 10 The Total Care Program has shown improvement in quality of life and reduction in medical utilization over time in preliminary analyses. 10 Three other examples of fully integrated models of care in academic centers are offered at the IBD Centers at Brigham and Women's Hospital, Vanderbilt University Medical Center, and Mount Sinai Medical Center. They use similar models of care where a social worker, psychologist, psychiatrist, and nurse educator provide behavioral health support. Stress management/mindbody programs are offered in addition to nutritional counseling and self-management tools via mobile applications and a dedicated website. 114 The model at Brigham and Women's Hospital was established with pilot funding through a pharmaceutical grant, whereas the one at Vanderbilt University Medical Center is self-funded and includes an imbedded pharmacist. Mount Sinai Medical Center is funded by philanthropy and more recently via the hospital through New York State Medicaid/Medicare funds (personal communication, November 12, 2016, Laurie Keefer). An integrated behavioral program for all of gastroenterology, with 20% having IBD, was piloted at Northwestern University. 83 Behavioral treatment consisted largely of cognitive behavioral therapy (44%) and hypnosis (48%). Reductions in gastrointestinal-related medical procedures after 6 months were robust for patients with functional gastrointestinal disorders. Such integrated programs also show promise in adults with irritable bowel syndrome. 115 A model program for behavioral integration into pediatric gastroenterology, which included patients with IBD, has also been published. 116 A standardized model to implement an IBD practice with psychosocial care has been developed by the IBD Support Foundation and published recently. 9 The IBD Support Foundation model now has been implemented in several academic medical centers and community practices including University of California San Diego, Mayo Clinic, Vanderbilt University Medical Center, University of Southern California, Texas Digestive Disease Consultants, and Gastro Health in Florida. These models use care algorithms outlined in IBD Support Foundation's Psychosocial Assessment and Intervention Protocols and are available in published form. 9 Each of these sites has piloted psychosocial care integration with funding from pharmaceutical grants, and randomized controlled trials are being conducted to determine its impact on health outcomes.
Outside of North America, models of integrated behavioral care in gastroenterology and specifically for IBD are published. In Europe, a value-based health care model focused on coordinated care, task differentiation of providers, and continuous home monitoring (using mobile health technologies) showed significantly fewer upper endoscopies, surgeries, hospitalizations, and emergency room visits compared with matched controls. 13, 117, 118 IBD-related costs were 16% ($771 per patient) less than expected during the 1-year study period. 13 Large health systems also have begun to develop telecommunications and telehealth programs as described in a recent review by Cross and Kane 119 to take care of the "whole patient". Multiple examples of effective use of telemedicine now are available from practices caring for patients with several chronic gastrointestinal disorders. 76, [120] [121] [122] [123] [124] [125] [126] [127] [128] A remote patient monitoring process using smartphone apps that integrate directly into a large health system electronic medical record (EMR) (Epic) has been developed at Mount Sinai Hospital in New York City. 76 Patient-reported outcomes and decision support tools interact with the EMR so providers can view information in real time during the usual course of patient visits without changing to another platform. Thus, patientreported symptoms become part of the foundational clinical record. This program has received a federal grant and is being evaluated as part of a multicenter, randomized controlled trial.
Finally, another program designed to engage patients and build a learning community among participating practices has been introduced by the Crohn's and Colitis Foundation of America called IBD Qorus. The program is designed to facilitate shared decision-making, leading to more consistent and evidence-based care. Working with the Institute for Healthcare Improvement, a Breakthrough Series Collaborative has been developed to focus on improved access for urgent care for patients (personal communication, February 8, 2017 , Alandra Weaver, MPH, Director IBD Qorus at Crohn's and Colitis Foundation of America).
Examples of Integrated Inflammatory Bowel Disease Care From Community Practices
Independent community practices are limited in their ability to provide psychosocial support, integrated IBD care, and non-reimbursable services (such as after-hours patient care). However, some have excelled at efficiency and patient-focused services, particularly in 4 areas: (1) facilitated care access for IBD patients, (2) use of EMR population analysis and alerts, (3) remote monitoring of patients outside the practice environment, and (4) financial support services. The task force identified a few specific examples, prioritizing in the order of research evidence, but we realize there are multiple examples of innovative care among community practices without published data that did not come to our attention.
Facilitated Access
One practice has developed facilitated IBD patient access and education (personal communication, June 17, 2016 , James Leavitt, MD). Every IBD patient is given a special swipe card containing registration and clinical information, allowing for fast track registration at each visit (reducing duplicate data entry). The practice has a dedicated IBD phone line during office hours that connects the patient to an IBD specialist immediately. Acute problems and walk-in patients are seen in the clinic on the same day.
Use of Electronic Medical Record for Population Health
Use of EMRs was encouraged by Medicare in 2009 when the Health Information Technology for Economic and Clinical Health Act was passed by Congress. Many practices use EMR's alerts to monitor lab results or schedule reminders and perform population level analysis of health outcomes. One practice we reviewed developed automated reminders to monitor lab results in patients on immunomodulator therapy (personal communication, August 23, 2016 , Joshua Colton, MD). In addition, by using International Classification of Disease, Ninth version codes for IBD, all unique patients within the practice were identified and screened for anemia, needed vaccinations, and other gaps in care, prompting ancillary staff to reach out to patients proactively.
Real-time decision support tools have been developed in the EMR such as standard order sets for patients beginning biologic therapies. Using coding and billing information to identify patients with specific disorders or diseases and then matching resources or medical interventions at a population level now is common in both community and academic practices. 76, [120] [121] [122] [123] [124] [125] [126] [127] [128] 
Remote Monitoring
Finally, innovative tools now exist that facilitate remote monitoring of patients outside the health care environment. The impact of remote monitoring on health outcomes was emphasized recently. 119 Medical care traditionally is reactive and based on patients seeking care when ill. Patients with chronic diseases such as IBD often become accustomed to the chronicity of symptoms and often present late during an exacerbation. During a review of administrative records from 21,000 Crohn's disease patients in 2011, researchers found that less than 30% had a billable physician encounter in the 30 days before a hospitalization. [125] [126] [127] On the basis of these preliminary findings, this same group developed a remote, smart-phone based monitoring system to determine whether facilitated patient communication might impact resource use. The program is a community-based registry and disease management process developed as a joint venture between a community practice and a large payer. Patients are screened at enrollment for depression and surveyed electronically monthly with a smartphone app that asks 5 questions from the Crohn's Disease Activity Index, one of which is a health-related quality of life question. [125] [126] [127] Patient responses are organized by using a proprietary cloud-based program (created by SonarMD, LLC, Chicago, IL) that yields a disease score that is combined with clinical data from the practice EMR, sent to a cloudbased data server, and integrated with embedded clinical decision support tools. These fields are then combined with claims data to provide comprehensive, real-time information to physicians and patients about trends in current symptoms and health status. The clinical decision support tools were based on the AGA's Crohn's Disease Care Pathway. 128 In another remote monitoring trial involving a consortium of academic and non-academic centers, Health-PROMISE, an app that evaluates patient gastrointestinal symptoms and quality of life, 320 patients enrolled over 2 sites showed significant engagement, satisfaction, and the following specific results: 129 Anxiety and fatigue were noted to be major drivers of poor quality of life scores.
Significant improvement in patient-reported quality of life among HealthPROMISE patients (mean, 30.3-25.2; P < .01) within 5 months (lower is better).
Increase in percentage of eligible quality indicators (quality metrics) met in HealthPROMISE arm (28%) versus control app (9%) (P < .01).
Financial Support Services
A large single specialty gastrointestinal (GI) practice in Minnesota developed (and internally funded) a group of 3 patient financial coordinators (PFCs) to help patients access expensive biological therapies for IBD. This model became financially self-sustaining because the practice avoided writing off bad debt accumulated from unpaid infusion charges (personal communication, August 23, 2016 , Joshua Colon, MD). Before development of this program, some patients accumulated unpaid balances greater than $25,000. PFCs effectively connected many patients with existing assistance programs (pharmaceutical companies, Medicaid, and foundations) that patients often were not using. Patients simply needed assistance navigating these programs. PFCs are involved from the first patient visit where a biologic therapy is considered. Through a notification system built into the practice EMR, the PFC team is alerted to contact appropriate patients, and they begin to determine benefits available, manage pre-authorizations, and coordinate assistance programs. A GI practice in south Florida has developed a similar process and coordinates therapies with specialty pharmacies that have been vetted for lowest out-of-pocket patient costs (personal communication, June 17, 2016, Dr James Leavitt).
Alternative Payment Models Supporting Integrated Care
The single largest barrier to implementing psychosocial care into routine IBD practice has been a lack of payment support within the current fee-for-service reimbursement system that is dominant in the United States. The Medicare Access and CHIP Reauthorization Act passed in 2015 mandated that the Centers for Medicare and Medicaid develop provider payment models that link reimbursement with quality and cost, termed value-based reimbursement, and include innovative "alternative payment models." 130 A type of alternative payment mode used by a large New Jersey-based payer is based on a total payment for an Episode of Care (EOC) of IBD including psychosocial care. Unlike fee-for-service where payment is made for all specific services delivered without regard to health outcomes or patient experience, this EOC model is based on all care delivered to a particular patient that is related to IBD across the full continuum of care. Payment is linked directly to a combination of quality outcomes, patient experience, and cost. Payments are based on retrospective adjudication, where providers are paid feefor-service and episodes that are completed during the measurement period are retrospectively evaluated against pre-agreed on metrics. If quality and patient experience metrics are met/exceeded and the costs come in under budget, the provider shares in the savings.
The goal of EOCs is to stratify patients so that like patients and like outcomes can be compared for purposes of studying variation in the utilization of services delivered and the cost of those services, so that both care and cost of care may become more standard and optimized. EOC models create accountability for care of the whole patient, including psychosocial components. As EOC models evolve, payers and employers will demand a comprehensive EOC for chronic IBD, including both medical and behavioral health-related costs to achieve health and life outcomes important to patients. Such programs will have the following characteristics:
1. Incorporate no/low risk to providers to allow for collaboration 2. Have upside potential for patient and provider 3. Be constructed to allow administration by both providers and payers 4. Be established for a long enough period to allow for effective care transformation 5. Avoid further aggravation of historic strained relations between payers and providers 6. Create a platform to migrate to accountability for care across the full continuum.
Initial EOC models are usually "upside only" where providers receive an incentive for exceeding targets (financial or quality) but are not at risk for failure. This approach affords a unique opportunity for providers and payers to truly collaborate. It takes time for transformations to take place for both providers and payers, so it is advisable to begin with a program that provides enough time (1-3 years) to allow for collaborative learning. The program then can be migrated to a twoside model or a prospective model in which providers accept full or partial financial risk.
Conclusion
Clearly, reforms in health care delivery and reimbursement are generating innovative care models as risk begins to be shared among patients, providers, purchasers of health care, and health systems in ways not previously seen. Mounting evidence about social and psychological determinants of health, health disparities, and cultural barriers to health points us in directions of a "Whole-Person" care paradigm. A recent systematic review and meta-analysis of 1824 studies with 14 randomized controlled trials comparing psychological therapy with a control intervention with usual medical therapy showed short-term benefit for such therapy but less effect on long-term disease activity. 131 This conclusion supports the conclusion of this white paper that psychosocial interventions cannot substitute for effective medical therapies, but evidence presented here suggests a combined, integrated approach will be of substantial value to IBD patients.
This white paper has outlined reasons for an integrative care model, specific tools to help construct the model, and working examples of patient-focused care. Innovative practices can use these tools and concepts to meet the challenges of emerging alternative payment models as we evolve our care delivery processes toward higher health value for our patients.
